Healthcare & aged care
Agents are moving into the clinical record. Governance has to move with them.
The lines that matter Cost per case, revenue-cycle days, claim denials and workforce cost
Regulators, health systems and pharmaceutical companies are already using agents for chart review, scheduling, prior authorisation and medical enquiries. That work sits right next to clinical judgement, which is where regulators are now looking.
Expectations are converging across the FDA, EMA, Singapore's MOH and HSA, and Australia's TGA: a defined context of use, lifecycle monitoring and named accountability. Organisations that redesign accountability before they scale will get the gains without the hidden risk.
- Workforce shortages and high agency and overtime costs
- Revenue leakage from coding errors and claim denials
- Bed capacity and patient flow
- Clinical safety and regulation as AI moves closer to care
- Clinical data across many systems with strict access rules
- Clinician time to design and test new workflows
- The line between administrative and regulated clinical use
- Privacy and consent requirements
Where AI can move the numbers
Opportunities grouped by Agent Value Ledger category. They are possibilities to test, not promised results.
Revenue
Revenue-cycle accuracy, funding classification, occupancy
Operating costs
Clinical documentation, rostering, scheduling, discharge planning
Capital
Faster claims payment, bed capacity, equipment utilisation
Risk
Incident detection, medication and documentation checks, audit readiness
The lines this sector is judged on
Hospitals and providers
- Net patient revenue
- Coding accuracy, claim denials, prior-authorisation preparation
- Cost per case
- Clinical documentation, scheduling, discharge planning
- Bed capacity and length of stay
- Patient-flow coordination and discharge readiness
- Workforce cost
- Rostering, agency staff and overtime
Pharma and life sciences
- R&D cost per trial
- Site selection, patient recruitment, trial documentation
- Time to revenue
- Preparation of regulatory submissions
- Commercial cost
- Medical information and field-team preparation
- Quality and compliance cost
- Pharmacovigilance case intake and quality records
Aged and community care
- Funding revenue
- Accurate care assessment and funding classification
- Care staff cost
- Time spent on notes and reporting
- Occupancy
- Enquiry handling and admissions
- Compliance cost
- Incident reporting and audit readiness
A revenue-cycle agent in a private hospital group
Assumptions: net patient revenue US$400m a year; claim denials at 8% of billed value, of which 40% is never recovered; 50 days of revenue in receivables; billing staff cost US$45 an hour; cost of capital 6%.
| Line | How the agent moves it | Measured by | Working | Per year |
|---|---|---|---|---|
| Revenue | Coding and documentation checked before claims go out | Denial rate; write-offs | 1 point fewer denials × US$400m × 40% unrecovered | +US$1.60m |
| Operating cost | Less rework of denied and queried claims | Rework hours per 1,000 claims | 20,000 hours × US$45, counted only if redeployed or hiring is avoided | +US$0.90m |
| Capital | Cleaner claims are paid sooner | Days in receivables | 5 days × US$400m ÷ 365 = US$5.5m released once, at 6% | +US$0.33m |
| Compliance | Fewer coding errors found in payer audits | Audit findings; clawbacks | Not counted until a full audit cycle | Excluded |
| Cost of the agent | Model usage, integration with patient systems, coder oversight, assurance | Total cost of ownership | Annual run cost | −US$0.70m |
| Net annual value | ≈ +US$2.1m, plus US$5.5m of cash released once | |||
Hypothetical illustration of the method. The figures are assumptions, not a client result or a forecast.
- A clear line between administrative agents and those that may be regulated as medical devices
- Clinical decisions remain human-reserved
- Drift monitoring and authority to suspend agents
AI Readiness & Value Diagnostics
Start with a revenue-cycle and workforce diagnostic, with clear separation of administrative and clinical use.
About this serviceHealthcare & Life Sciences in the Age of Agency
Health organisations that redesign accountability before they deploy AI agents at scale will get the productivity gains; those that skip that step will take on clinical and regulatory risk they cannot see.
Read the brief →Agents inside the clinical record
Situation. A hospital group's agents prepare patient summaries and discharge paperwork. Departments now want their own, and some agents are drifting towards clinical suggestions.
Our approach. An agent register, a clear line between administrative and clinical use, drift monitoring with authority to suspend, and governance built to the strictest market's standard.
What good looks like. Departments build within clear limits, and regulators in every market see one consistent approach.
Scenarios and worked ledgers are hypothetical illustrations. They do not describe specific clients.
Start with an executive conversation
A confidential discussion of your priorities, and where AI could move the numbers in your business.